Cargando…

Atypical femoral fracture in the setting of alendronate treatment for osteoporosis: a case report and literature review

Osteoporosis leads to reduced bone mass and disrupted bone architecture. Bisphosphonates are used to treat osteoporosis by inhibiting bone resorption. Chronic bisphosphonate use has been associated with adverse effects including atypical femoral fractures (AFF). We report the case of a 63-year-old w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Baarsel, Eric D., Patel, Vandan, Kesbeh, Yazeed, Kahf, Huthayfa, Alonzo, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735290/ https://www.ncbi.nlm.nih.gov/pubmed/31528285 http://dx.doi.org/10.1080/20009666.2019.1644894

Ejemplares similares

Approach to pediatric rotational limb deformities
por: Kahf, Huthayfa, et al.
Publicado: (2019)

Spinal epidural abscess secondary to gram-negative bacteria: case report and literature review
por: Van Baarsel, Eric D., et al.
Publicado: (2020)

Atypical fracture of the ulna associated with alendronate use
por: Bjørgul, Kristian, et al.
Publicado: (2011)

Bilateral Atypical Femoral Fractures after Bisphosphonate Treatment for Osteoporosis: A Literature Review
por: Hwang, SeokJoon, et al.
Publicado: (2023)

Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature
por: Iwamoto, Jun, et al.
Publicado: (2008)

Discontinuation of alendronate and administration of bone-forming agents after surgical nailing may promote union of atypical femoral fractures in patients on long-term alendronate therapy
por: Lin, Tsung-Li, et al.
Publicado: (2013)

Alendronate Sodium in the Management of Osteoporosis
por: Prinsloo, P J J, et al.
Publicado: (2006)

Effects of pentoxifylline and alendronate on fracture healing in ovariectomy-induced osteoporosis in rats
por: Vashghani Farahani, Mohammad-Mahdi, et al.
Publicado: (2019)

Association between alendronate and atypical femur fractures: a meta-analysis
por: Liu, Lu, et al.
Publicado: (2015)

AN ‘ATYPICAL’ ATYPICAL FEMORAL FRACTURE
por: Arneill, Richard, et al.
Publicado: (2019)

Atypical Femoral Fracture Combined with Osteonecrosis of Jaw During Osteoporosis Treatment with Bisphosphonate
por: Won, Yougun, et al.
Publicado: (2014)

Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis
por: Leder, Benjamin Z, et al.
Publicado: (2019)

Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy
por: Gudena, Ravindra, et al.
Publicado: (2011)

Spontaneous Subtrochanteric Femoral Stress Fracture Related to Alendronate : A Case Report
por: Chew, Paul CC, et al.
Publicado: (2013)

Alendronate improves QOL of postmenopausal women with osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2010)

Effects of alendronate sodium combined with InterTan on osteoporotic femoral intertrochanteric fractures and fracture recurrence
por: Wang, Ke-Meng, et al.
Publicado: (2022)

Do Estrogen and Alendronate Improve Metaphyseal Fracture Healing When Applied as Osteoporosis Prophylaxis?
por: Kolios, Leila, et al.
Publicado: (2009)

ERRATUM for “Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis”
Publicado: (2020)

Pernicious anemia: a myelodysplastic syndrome look-alike
por: Kesbeh, Yazeed, et al.
Publicado: (2019)

Role of Alendronate in Managing Osteoporosis in Celiac Disease – Illustrative Case Report
por: Widjaja, David, et al.
Publicado: (2011)

Effect of Age and Sodium Alendronate on Femoral Fracture Repair: Biochemical and Biomechanical Study in Rats
por: Bonetto, Luana Mordask, et al.
Publicado: (2021)

A Case Report of Oral Bisphosphonate Treatment for Osteoporosis Leading to Atypical Femoral Fracture and Pathologic Mandibular Fracture
por: Fernandes, Tito Lúcio, et al.
Publicado: (2023)

Is vitamin K(2) a treatment choice for atypical femoral fractures in patients with secondary osteoporosis?
por: Wang, Bingzhang, et al.
Publicado: (2021)

Incidence of Atypical Femoral Fractures in Patients on Osteoporosis Therapy—A Registry‐Based Cohort Study
por: Everts‐Graber, Judith, et al.
Publicado: (2022)

A Periprosthetic Femoral Fracture with Characteristics of Atypical Femoral Fracture
por: Tanaka, Shuya, et al.
Publicado: (2019)

Denosumab and atypical femoral fractures
por: Aspenberg, Per
Publicado: (2014)

Atypical femoral fractures and bisphosphonates
por: Jawad, Ali S. M.
Publicado: (2017)

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
por: Kim, Yeesuk, et al.
Publicado: (2020)

Fracture Risk Following an Atypical Femoral Fracture
por: Bégin, Marie‐Josée, et al.
Publicado: (2021)

Lateral Femoral Bowing and the Location of Atypical Femoral Fractures
por: Yoo, Hyunseung, et al.
Publicado: (2017)

Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2010)

The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies
por: Chen, Ling-Xiao, et al.
Publicado: (2015)

A critical review of brand and generic alendronate for the treatment of osteoporosis
por: Brown, Jacques P, et al.
Publicado: (2013)

Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women
por: Um, Mi Jung, et al.
Publicado: (2017)

Surgical and Pharmacological Management of Periprosthetic Atypical Femoral Fractures: A Narrative Literature Review
por: Troiano, Elisa, et al.
Publicado: (2022)

Atypical femoral fractures and current management
por: Zheng, Nianye, et al.
Publicado: (2016)

Atypical Fracture of the Sternum After Long-Term Alendronate Plus Cholecalciferol Treatment: A Case Report
por: Martín Arias, Luis H., et al.
Publicado: (2017)

Osteonecrosis of the Jaw and Bilateral Atypical Femoral Fracture Both Occurring During Treatment for Osteoporosis: A Case Report
por: Payumo, Edelissa, et al.
Publicado: (2018)

How Efficient are Alendronate-Nano/Biomaterial Combinations for Anti-Osteoporosis Therapy? An Evidence-Based Review of the Literature
por: Klara, Joanna, et al.
Publicado: (2022)

Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures
por: Iwamoto, Jun, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_pb1s2c7a07vsehem48dh3jqt39